Category Archives: AZBio News
Flagship Biosciences establishes Quality Management System for the development of Medical Device Software
Flagship Biosciences establishes a Quality Management System (QMS) for the development of medical device software to bring image analysis based Companion Diagnostics (CDx) into the clinical market. Continue reading
FDA approves new therapy for pancreatic cancer patients
International clinical trial led by TGen and HonorHealth showed significant overall survival ratesContinue reading
AZBio Honors Ten Arizona Legislators as 2015 Trailblazers
AZBio Trailblazers are selected annually and recognized for their leadership in supporting research, education, innovation and the growth of Arizona’s bioscience sector by the Arizona Bioindustry Association.Continue reading
Flagship launches new website to highlight areas of clinical focus
Flagship Biosciences, the largest tissue image analysis provider for the drug development industry, is pleased to announce a website redesign, which highlights our advanced technology and clinical readiness needed to support image analysis based companion diagnostic strategies for the pharmaceutical industry.Continue reading
AZBio Chairman Takes Home Internationalist Award For Work at Pinnancle Transplant Technologies
Internationalist Award Showcases Pinnacle Transplant Technologies’ Efforts Across Borders
Regenerative medical company working with City of Phoenix and Arizona Commerce Authority, among others, to expand international export opportunities for its innovative allograft productsContinue reading
LabLeaders educational initiative to help redefine the value of the laboratory
First Launched at the AACC 2015 Clinical Lab Expo in August 2015, the Roche LabLeaders educational initiative is designed to help redefine the value of the laboratory with a suite of online and live educational workshops. Continue reading
Protein found in malaria could help stop cancer
Malarial protein binds to a sugar molecule found many types of cancer, enabling anti-cancer drugs to target tumorsContinue reading